首页 | 本学科首页   官方微博 | 高级检索  
     

腺病毒介导的肝癌自杀基因疗法的实验研究
引用本文:黄欣,曹雪涛,章卫平,鞠佃文,张明徽,肖农,陈国友,万涛,HirofumiHamada. 腺病毒介导的肝癌自杀基因疗法的实验研究[J]. 中国肿瘤生物治疗杂志, 1996, 3(4): 280-284
作者姓名:黄欣  曹雪涛  章卫平  鞠佃文  张明徽  肖农  陈国友  万涛  HirofumiHamada
作者单位:[1]第二军医大学免疫学教研室上海200433 [2]日本东京癌症化疗中心分子生物治疗研究部
基金项目:国家自然科学基金,优秀中青年人才专项基金(39421009)
摘    要:本文观察了胞嘧啶脱氨酶(CD)基因/5-氟胞嘧啶(5FC)自杀基因疗法对肝癌模型的治疗作用。以CMV启动子调控CD基因的重组腺病毒载体AdexCMV.CD在体外能有效转染人肝癌细胞株SMMC-7721和HepG2,转染后的细胞体外生长能力无明显变化,对5FC的敏感性明显增高。当以AFP上游调控序列驱动CD基因的重组腺病毒载体AdexAFP.CD分别转染SMMC-7721和HepG2时,CD基因能在HepG2中表达,使HepG2对5FC的敏感性增高,但不能使SMMC-7721的生长受到5FC的抑制。[~3H]TdR掺入法观察体外旁观者效应时发现,当细胞总数中转染细胞数超过20%时,其生长明显被5FC抑制。将AdexCMV.CD直接注射入裸鼠接种SMMC-7721细胞形成的皮下肿瘤中,并全身应用5FC后,与对照组相比,肿瘤大小在开始治疗后第8天约缩小3倍,第18天约缩小4倍,以上结果表明,腺病毒介导的CD/5FC自杀基因系统能在体内、外有效地抑制肝癌的生长。以AFP上游调控序列驱动CD基因的腺病毒载体介导的基因转染能在AFP阳性的肝癌细胞中特异表达。

关 键 词:胞嘧啶脱氨酶基因  5-氟胞嘧啶  腺病毒  肝细胞癌  基因治疗
收稿时间:1996-02-26
修稿时间:1996-06-29

xperimental Study on Adenovirus-Mediated Suicide Gene Therapy for Human Hepatucellular Carcinoma Using Escherichia Coli Cytosine Deaminase
Huang Xin,Cao Xuetao,Zhang Weiping,Ju Tianwen,Zhang Minghui,Xiao Nong,Chen Guoyou,Wan Tao and HirofumiHamada. xperimental Study on Adenovirus-Mediated Suicide Gene Therapy for Human Hepatucellular Carcinoma Using Escherichia Coli Cytosine Deaminase[J]. Chinses Journal of Cancer Biotherapy, 1996, 3(4): 280-284
Authors:Huang Xin  Cao Xuetao  Zhang Weiping  Ju Tianwen  Zhang Minghui  Xiao Nong  Chen Guoyou  Wan Tao  HirofumiHamada
Affiliation:Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433;Department of Immunology, Second Military Medical University, Shanghai, 200433
Abstract:To evaluate whether in vitro and in vivo transfer of E. Coli cytosine deaminase gene will confer sensitivity of a solid tumor to prodrug 5-fluorocytosine(5FC), we used an adenovirus vector(AdexCMV. CD) carrying the cytosine deaminase gene driven by the CMV promoter, infected SMMC-7721 or HepG2 cells hepatocellular carcinoma cells in vitro, and found AdexCMV. CD vector could effectively suppressed the growth of SMMC-7721 and HepG2 cells. When the two cells were infected with AdexAFP. CD vector in which the CD gene was driven by the AFP gene 5'-flanking region, only HepG2 cells were conferred sensitivity to 5FC. (Infection with AdexCMV.CD, when as few as 20% of cells transfected the CD gene, SMMC-7721 cells were associated with a bystander effect when combined with 5FC in cell mixing studies.) Consistent with these in vitro observations, AdexCMV. CD was directly injected into established subcutaneous SMMC-7721 tumors in nude mice receiving 5FC,there was a 60% reduction in tumor size at day 8, 70% reduction at day 24. Our results suggested that adenovirus-mediated tumor-specific gene transfer of CD gene and concomitant administration of 5 FC may have potential as a strategy for local control of tumor growth.
Keywords:cvtosine deaminase gene  5-fluorocytosine  adenovirus  hepatocellular careinoma  gene therapy  
本文献已被 维普 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号